Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation.
about
Vaccine adjuvants: mode of actionVaccines with aluminum-containing adjuvants: optimizing vaccine efficacy and thermal stabilityChoice and Design of Adjuvants for Parenteral and Mucosal VaccinesH5N1 vaccines in humansAdvances in aluminum hydroxide-based adjuvant research and its mechanismTRIF is a critical negative regulator of TLR agonist mediated activation of dendritic cells in vivoEngineering an effective immune adjuvant by designed control of shape and crystallinity of aluminum oxyhydroxide nanoparticlesMolecular and cellular signatures of human vaccine adjuvants.Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: results of a phase I-II randomized clinical trial.Novel Ricin Subunit Antigens With Enhanced Capacity to Elicit Toxin-Neutralizing Antibody Responses in Mice.Priming Vaccination With Influenza Virus H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination.Production and preclinical evaluation of Plasmodium falciparum MSP-119 and MSP-311 chimeric protein, PfMSP-Fu24Recent progress in adjuvant discovery for peptide-based subunit vaccinesEnhanced specific immune responses by CpG DNA in mice immunized with recombinant hepatitis B surface antigen and HB vaccine.Increasing the potency of an alhydrogel-formulated anthrax vaccine by minimizing antigen-adjuvant interactionsTowards an understanding of the adjuvant action of aluminium.Formulation of a killed whole cell pneumococcus vaccine - effect of aluminum adjuvants on the antibody and IL-17 response.Unequivocal identification of intracellular aluminium adjuvant in a monocytic THP-1 cell line.A method of lyophilizing vaccines containing aluminum salts into a dry powder without causing particle aggregation or decreasing the immunogenicity following reconstitution.Adjuvants for vaccines to drugs of abuse and addiction.Efficient extraction of vaccines formulated in aluminum hydroxide gel by including surfactants in the extraction buffer.Properties and prospects of adjuvants in influenza vaccination - messy precipitates or blessed opportunities?Local response to microneedle-based influenza immunization in the skin.Developing a vaccine against multiple psychoactive targets: a case study of heroin.Patterns of binding of aluminum-containing adjuvants to Haemophilus influenzae type b and meningococcal group C conjugate vaccines and componentsSynthesis and preclinical evaluation of QS-21 variants leading to simplified vaccine adjuvants and mechanistic probesParticle-based platforms for malaria vaccines.Adsorption of recombinant poxvirus L1-protein to aluminum hydroxide/CpG vaccine adjuvants enhances immune responses and protection of mice from vaccinia virus challengeA novel hepatitis B vaccine containing Advax™, a polysaccharide adjuvant derived from delta inulin, induces robust humoral and cellular immunity with minimal reactogenicity in preclinical testing.Comparative efficacy of two leading candidate ricin toxin a subunit vaccines in mice.Toward understanding the mechanism underlying the strong adjuvant activity of aluminum salt nanoparticles.Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome.Applications of nanomaterials as vaccine adjuvants.Phosphate substitution in an AlOOH - TLR4 adjuvant system (SPA08) modulates the immunogenicity of Serovar E MOMP from Chlamydia trachomatisDevelopment of a Direct Alhydrogel Formulation Immunoassay (DAFIA).Comparison of adjuvant and adjuvant-free murine experimental asthma modelsUse of o-phthalaldehyde assay to determine protein contents of Alhydrogel-based vaccines.Human prophylactic vaccine adjuvants and their determinant role in new vaccine formulations.Vaccine adjuvants: scientific challenges and strategic initiatives.Development of prophylactic and therapeutic vaccines using the ISCOMATRIX adjuvant.
P2860
Q21131210-705917FA-1641-46AD-AE49-1DED775065E4Q24634332-70C2FBBF-252B-4BF1-B6E3-F8FEA1F5640FQ26783488-09FCEF7B-F9EC-48BD-BAA5-744A59F0A0E8Q27000896-A9C648B7-879E-4069-8112-A7AEA9D8E246Q27007659-C43DABB6-CFB3-440D-A98B-E53B0589DC0FQ27332276-DA2BA290-AA85-4121-89A5-9B34923F13B8Q28394668-6C713F5E-8C13-48CC-B344-5B98A962205EQ30370898-634CDCB5-33B2-405F-9EB3-FD8E37757EDBQ30372195-C47C50D7-81E8-4638-B0D0-CF7E58B0021BQ30385759-1EA7E14D-3C0C-4348-9845-F1FF74BC62A3Q30390832-69B19F6A-86DC-4637-97C1-3EB85B85F459Q33743450-4DB6F4C7-6BEE-4996-98E0-EEB6FB99A389Q34033780-23ACD4BC-FADF-48EA-A9DA-76C7A6550EF9Q34633541-6CBD1BC8-848A-4848-A13B-B686934B584FQ34976001-FDFCFBD7-CCE9-4348-BE41-4085FA213C28Q35138579-5EF0D099-7DDA-4CAB-B72C-93B6615C5816Q35181390-6D6874B2-B0B1-4EAF-9F18-6CD14CB34440Q35239021-D9031F99-F9D8-4910-A725-2A582EC6EE6FQ35268788-7EFA9479-39F1-435D-93E7-24630DEC1BF1Q35493923-DB5CDAF2-4DF7-480F-B925-AD016EF38612Q35634133-B34B18AB-1079-44B1-934F-7D0F5544F351Q35664854-26D620B3-4B53-4D1A-8BF3-53011398B305Q35826992-A3260952-4AE9-4BBB-81EA-CDE3AB54F8CFQ35892296-89CE1477-6505-44AC-9F75-6ADC3542B203Q36090625-5012AA57-507C-4F9D-8B59-7AC86B1C85CAQ36216866-C5D3C72D-A434-4B64-8ED2-73370B344BC2Q36396040-9692AD60-7757-48B5-B3C2-E1CD1054F710Q36487366-4C76D8E1-22EF-42DA-9734-2AF073520639Q36711264-B4BE8DF6-8C69-4FA9-95A2-2F49CCA3B2D6Q36911310-DFA502B0-DB89-4AEC-A34F-81510123BF59Q37036694-CCFE1F9C-4850-4461-A5E9-F6D743675D20Q37070610-A70BF6BF-0B3F-4CE9-90ED-DC4F6F63C0F4Q37159697-C9C65B51-15DF-4C7B-91AD-4B775809A310Q37264979-30A75829-6224-4A16-831B-4C20844D958FQ37265775-EB53CC6C-D158-4AC6-83A6-DCA3AFB47856Q37310428-52148142-7BD0-479D-9236-24256BFD894EQ37366748-7AE74B09-A9A4-49B1-93B9-0215FB67C454Q37371036-6A7CD974-CE97-4630-AE0D-FFEB3B8F690AQ37403484-E09B09A3-F67D-49DA-8B42-20DE51C12FA1Q37452772-BD620744-9CC7-4AA5-B8F5-BBCF63410708
P2860
Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Relationship between physical ...... uvants and immunopotentiation.
@en
type
label
Relationship between physical ...... uvants and immunopotentiation.
@en
prefLabel
Relationship between physical ...... uvants and immunopotentiation.
@en
P2860
P356
P1476
Relationship between physical ...... uvants and immunopotentiation.
@en
P2093
Harm Hogenesch
Stanley L Hem
P2860
P304
P356
10.1586/14760584.6.5.685
P577
2007-10-01T00:00:00Z